Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions, including contraception; treatment or prevention of fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas; hormone replacement therapy; stimulation of food intake; and estrus synchronization.